NDC 62135-496 – Griseofulvin MICROSIZE
Griseofulvin 500 mg/1 · Tablet · Oral
Product NDC62135-496
Product details
- Brand name
- Griseofulvin MICROSIZE
- Generic name
- Griseofulvin
- Labeler
- Chartwell RX, LLC.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA060569
- Marketed since
- September 9, 1971
- Listing expires
- December 31, 2026
- Pharmacologic class
- Tubulin Inhibiting Agent
Active ingredients
- Griseofulvin 500 mg/1
Uses, dosage, side effects and warnings for Griseofulvin MICROSIZE →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 62135-496-01 | 100 TABLET in 1 BOTTLE (62135-496-01) | Dec 31, 2020 |
| 62135-496-30 | 30 TABLET in 1 BOTTLE (62135-496-30) | Dec 31, 2020 |
Other Griseofulvin MICROSIZE products
- 23155-865 Griseofulvin 500 mg/1 · Tablet · Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc